BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34750514)

  • 1. Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank.
    De Vincentis A; Tavaglione F; Spagnuolo R; Pujia R; Tuccinardi D; Mascianà G; Picardi A; Antonelli Incalzi R; Valenti L; Romeo S; Vespasiani-Gentilucci U
    Int J Obes (Lond); 2022 Mar; 46(3):486-493. PubMed ID: 34750514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank.
    Tavaglione F; De Vincentis A; Jamialahmadi O; Pujia R; Spagnuolo R; Picardi A; Morano S; Valenti L; Romeo S; Vespasiani-Gentilucci U
    JHEP Rep; 2021 Jun; 3(3):100262. PubMed ID: 33997749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive value of body mass index combined with waist circumference for new-onset nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus].
    Wang S; Zhang J; Zhang W; Wang H; Hou J; Zhang R; Liu H; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1293-1297. PubMed ID: 31852647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint associations of adiposity and alcohol consumption with liver disease-related morbidity and mortality risk: findings from the UK Biobank.
    Inan-Eroglu E; Huang BH; Ahmadi MN; Johnson N; El-Omar EM; Stamatakis E
    Eur J Clin Nutr; 2022 Jan; 76(1):74-83. PubMed ID: 34059777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between walking pace and incident type 2 diabetes by adiposity level: A prospective cohort study from the UK Biobank.
    Boonpor J; Parra-Soto S; Gore J; Talebi A; Lynskey N; Raisi A; Welsh P; Sattar N; Pell JP; Gill JMR; Gray SR; Ho FK; Celis-Morales CA
    Diabetes Obes Metab; 2023 Jul; 25(7):1900-1910. PubMed ID: 36951683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
    Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic risk factors, genetic predisposition, and risk of severe liver disease in Chinese: a prospective study of 0.5 million people.
    Pang Y; Lv J; Kartsonaki C; Yu C; Guo Y; Chen Y; Yang L; Millwood IY; Walters RG; Wang S; Chen J; Chen Z; Li L
    Am J Clin Nutr; 2021 Aug; 114(2):496-504. PubMed ID: 33964851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 9. [Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study].
    Yang XY; Zhang M; Luo XP; Wang JJ; Yin L; Pang C; Wang GA; Shen YX; Wu DT; Zhang L; Ren YC; Wang BY; Zhang HY; Zhou JM; Han CY; Zhao Y; Feng TP; Hu DS; Zhao JZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):328-33. PubMed ID: 27029364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BMI and waist circumference with diabetic microvascular complications: A prospective cohort study from the UK Biobank and Mendelian randomization analysis.
    Huang Y; Zhang X; Li B; Zhu X; Li C; Zhou C; Gu C; Wang Y; Ma M; Fan Y; Xu X; Chen H; Zheng Z
    Diabetes Res Clin Pract; 2023 Nov; 205():110975. PubMed ID: 37884062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores.
    De Vincentis A; Tavaglione F; Jamialahmadi O; Picardi A; Antonelli Incalzi R; Valenti L; Romeo S; Vespasiani-Gentilucci U
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):658-673. PubMed ID: 34091049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifiable lifestyle factors, genetic and acquired risk, and the risk of severe liver disease in the UK Biobank cohort: (Lifestyle factors and SLD).
    Liu Z; Huang H; Xie J; Shen QE; Xu C
    Dig Liver Dis; 2024 Jan; 56(1):130-136. PubMed ID: 37407315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waist Circumference and Body Mass Index Variability and Incident Diabetic Microvascular Complications: A Post Hoc Analysis of ACCORD Trial.
    Hukportie DN; Li FR; Zhou R; Zheng JZ; Wu XX; Wu XB
    Diabetes Metab J; 2022 Sep; 46(5):767-780. PubMed ID: 35584801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central obesity and its association with retinal age gap: insights from the UK Biobank study.
    Chen R; Zhang J; Shang X; Wang W; He M; Zhu Z
    Int J Obes (Lond); 2023 Oct; 47(10):979-985. PubMed ID: 37491535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study.
    ; Langenberg C; Sharp SJ; Schulze MB; Rolandsson O; Overvad K; Forouhi NG; Spranger J; Drogan D; Huerta JM; Arriola L; de Lauzon-Guillan B; Tormo MJ; Ardanaz E; Balkau B; Beulens JW; Boeing H; Bueno-de-Mesquita HB; Clavel-Chapelon F; Crowe FL; Franks PW; Gonzalez CA; Grioni S; Halkjaer J; Hallmans G; Kaaks R; Kerrison ND; Key TJ; Khaw KT; Mattiello A; Nilsson P; Norat T; Palla L; Palli D; Panico S; Quirós JR; Romaguera D; Romieu I; Sacerdote C; Sánchez MJ; Slimani N; Sluijs I; Spijkerman AM; Teucher B; Tjonneland A; Tumino R; van der A DL; van der Schouw YT; Feskens EJ; Riboli E; Wareham NJ
    PLoS Med; 2012; 9(6):e1001230. PubMed ID: 22679397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank.
    Chahal D; Sharma D; Keshavarzi S; Arisar FAQ; Patel K; Xu W; Bhat M
    Hepatol Int; 2022 Apr; 16(2):325-336. PubMed ID: 35178663
    [TBL] [Abstract][Full Text] [Related]  

  • 17.  Ultra-processed food consumption and risk of obesity: a prospective cohort study of UK Biobank.
    Rauber F; Chang K; Vamos EP; da Costa Louzada ML; Monteiro CA; Millett C; Levy RB
    Eur J Nutr; 2021 Jun; 60(4):2169-2180. PubMed ID: 33070213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease, and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking.
    Jenkins DA; Bowden J; Robinson HA; Sattar N; Loos RJF; Rutter MK; Sperrin M
    Diabetes Care; 2018 Sep; 41(9):1878-1886. PubMed ID: 29970414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies.
    Fontvieille E; Viallon V; Recalde M; Cordova R; Jansana A; Peruchet-Noray L; Lennon H; Heath AK; Aune D; Christakoudi S; Katzke V; Kaaks R; Inan-Eroglu E; Schulze MB; Mellemkjær L; Tjønneland A; Overvad K; Farràs M; Petrova D; Amiano P; Chirlaque MD; Moreno-Iribas C; Tin Tin S; Masala G; Sieri S; Ricceri F; Panico S; May AM; Monninkhof EM; Weiderpass E; Gunter MJ; Ferrari P; Freisling H
    BMC Med; 2023 Nov; 21(1):418. PubMed ID: 37993940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of a new body shape index and body adiposity estimator for development of type 2 diabetes mellitus: The Rural Chinese Cohort Study.
    Han C; Liu Y; Sun X; Luo X; Zhang L; Wang B; Ren Y; Zhou J; Zhao Y; Zhang D; Liu X; Zhang M; Hu D
    Br J Nutr; 2017 Nov; 118(10):771-776. PubMed ID: 29143718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.